Full Press Release Details
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing.
SLDB
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing
Key Takeaway: Solid Biosciences Reports Inducement Grant Under Nasdaq Listing
Price reaction · baseline $5.67 (2024-06-28 close) · clean, no other SLDB news in the window
day 0 close · peak
+10.6%
day 1
+5.1%
day 3
+3.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma